References
- Wingrave S. J., Kay C. R., Vessey M. P. Oral contraceptives and diabetes. Br. Med. J. 1979; 1: 23
- Duffy T. J., Ray R. Oral contraceptive use: prospective follow up of women with suspected glucose intolerance. Contraception 1984; 30: 197–208
- Gaspard U. J., Lefebvre P. J. Clinical assessment of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism and the development of cardiovascular disease. Am. J. Obstet. Gynecol. 1990; 163: 334–43
- Gaspard U. J. Carbohydrate metabolism in oral contraceptive users. Fertil. Control Rev. 1993; 2: 13–17
- Reaven G. M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
- Scheen A. J., Jandrain B. J., Humblet D. M., Jaminet C. B., Gaspard U. J., Lefebvre P. J. Effect of a one year treatment with a low-dose combined oral contraceptive containing ethinylestradiol and cyproterone acetate on glucose and insulin metabolism. Fertil. Steril. 1993; 59: 797–802
- Godsland I. F., Walton C., Felton C., Prouder A., Patel A., Wynn V. Insulin resistance, secretion and metabolism in users of oral contraceptives. J. Clin. Endocrinol. Metab. 1992; 74: 64–70